摘要 |
1512400 16,17-Naphthopregnenes E R SQUIBB & SONS Inc 13 Nov 1975 [25 Nov 1974] 46902/75 Heading C2U The invention comprises #<SP>4</SP> and #<SP>1'4</SP> steroids of formula wherein R 1 is Cl, F or OH; R<SP>1</SP> 1 is H; or R 1 and R<SP>1</SP> 1 together are oxo; R 2 is H or halo; R 3 is H, Me or F; R 4 is H, OH, C 2-7 alkanoyloxy, halo or benzoyloxy (optionally substituted by C 1-6 alkyl, C 1-6 alkoxy or halo); R 5 and R 6 are each H, OH, halo, Ph, CN, CHO, C 1-6 alkyl, C 1-6 alkylthio, C 1-6 alkoxy, C 2-7 carbalkoxy, C 2-7 alkanoyl or C 2-7 alkanoyloxy, with the provisos that (i) when R 6 is H then R 5 is-H, and (ii) when R 5 and R 6 are different then one of them is H; and their preparation from the corresponding 16, 17-unsubstituted #<SP>16</SP> steroids or 9,11,16,17-unsubstituted #<SP>9(11),16</SP> steroids by reaction with a compound of formula followed by halogenation or hydroxyhalogenation across any 9,11-double bond in the product. Compounds I are interconvertible by (i) hydrolysis of 21-acyloxy; (ii) conversion of 21-OH to 21-halo (e.g. via a 21-mesylate); and (iii) conversion of a 9-bromo-11#-ol via a 9,11- epoxide to a 9-(fluoro or iodo)-11#-ol. Specified intermediates in the above processes are 21 - mesyloxy - 9 - fluoro - 1<SP>1</SP>,2<SP>1</SP>,3<SP>1</SP>,4<SP>1</SP>,- tetrahydro - 11# - hydroxypregna - 1,4 - dieno- [16α,17 - b]naphthalene - 3,20 - dione (Ex. 8): 21 - acetoxy - 4<SP>1</SP># - ethyl - 6α - fluoro - 1<SP>1</SP>,2<SP>1</SP>,3<SP>1</SP>,4<SP>1</SP>- tetrahydropregna - 1,4,9(11) - trieno[16α,17 - b]- naphthalene - 3,20 - dione (Ex. 25); and 21- acetoxy - 1<SP>1</SP>,2<SP>1</SP>,3<SP>1</SP>,4<SP>1</SP> - tetrahydro - 4<SP>1</SP># - phenylpregna - 1,4,9(11) - trieno[16α,17 - b]naphthalene- 3,20-dione (Ex. 26). Compounds I are credited with glucocorticoid and anti-inflammatory activity, and may be made up with carriers into pharmaceutical compositions for oral and topical administration. |
申请人 |
E.R. SQUIBB AND SONS,INC,US |
发明人 |
VARMA,RAVI K.,US;CIMARUSTI,CHRISTOFER M.,US |